Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001356090-25-000019
Filing Date
2025-05-14
Accepted
2025-05-14 16:23:03
Documents
81
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pgen-20250331.htm   iXBRL 10-Q 964985
2 EX-31.1 pgen-20250331xexx311.htm EX-31.1 10375
3 EX-31.2 pgen-20250331xexx312.htm EX-31.2 10038
4 EX-32.1 pgen-20250331xexx321.htm EX-32.1 5801
5 EX-32.2 pgen-20250331xexx322.htm EX-32.2 5878
  Complete submission text file 0001356090-25-000019.txt   6296021

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pgen-20250331.xsd EX-101.SCH 44781
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pgen-20250331_cal.xml EX-101.CAL 77283
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pgen-20250331_def.xml EX-101.DEF 218010
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pgen-20250331_lab.xml EX-101.LAB 665131
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pgen-20250331_pre.xml EX-101.PRE 445321
84 EXTRACTED XBRL INSTANCE DOCUMENT pgen-20250331_htm.xml XML 729736
Mailing Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876 301-556-9900
PRECIGEN, INC. (Filer) CIK: 0001356090 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36042 | Film No.: 25946065
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)